HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

More than 300 under-performing SKUs, representing one-quarter of Dial's product line, have been eliminated, CEO Herbert Baum announces during Dial's annual stockholders meeting June 7 in Scottsdale, Ariz. Reductions primarily taken from Specialty Personal Care division, firm says. Dial vowed in September to cut almost half, or 260 SKUs, from its existing 615 in the SPC category (1"The Rose Sheet" Sept. 25, 2000, p. 5). Firm continues to evaluate sale of SPC division, and "proceeds from the sale of any assets will be used to reduce debt," Baum says. Debt was reduced by $60 mil. in second half of 2000 and will be reduced by $80 mil.-$90 mil. more in 2001. Total debt at year end will be $500 mil., firm predicts. Baum reconfirmed sales growth estimates of 5% for 2001

You may also be interested in...

Dial Specialty Personal Care Reduced By 42%, Nature's Accents Discontinued

Dial Corp. is shedding almost half its Specialty Personal Care SKUs, including the unprofitable Nature's Accents line, under a strategic plan to be implemented by newly appointed CEO Herbert Baum, the exec announced at an investor meeting in New York City Sept. 22.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts